Indianapolis, INNCT05386043Now EnrollingIRB Ready

Glioma Clinical Trial in Indianapolis, IN

Access cutting-edge glioma treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Indiana University

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions…

Expert Care in Indianapolis

Access glioma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related glioma treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this glioma clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Glioma Study in Indianapolis

This study is investigating how brain tumors might mutate over time, and whether new brain imaging tools like MRI and PET can predict these mutations.

Sponsor: Indiana University

Who Can Participate

Inclusion Criteria

Subject is between 18 and 89 years of age.
Subject has radiologically-diagnosed or suspected WHO Grade II-IV glioma based on physician review or conformance with published WHO criteria as evaluated by the PI\*.
Subject is treatment-naïve with the exception of previous biopsy for the above condition.
Subject is planning to undergo surgical resection and biopsy of their brain tumor.
Subject has sufficient tissue so that the study team is able to acquire at least 2 biopsy samples during resection.
Subject is able to read and write in English.
Subject is able to lay supine for up to 80 minutes.
Subject is able to hold still during MRI procedures.
Subject or their LAR has signed the consent form for participation in the study.

Exclusion Criteria

Subject has conditions that would preclude the completion of an MRI such as claustrophobia, pacemaker, metal objects in the body, and/or pregnancy.
Subject has serious unstable medical or mental illness.
Subject has insufficient tissue to acquire at least two biopsy samples during resection.
Subject has a medical contraindication to any element of the study procedures.
Subject or their LAR has not read and signed the informed consent form, or does not understand its contents.
Subject is pregnant.\*\
Subject is at high risk for NSF (eGFR\<60 or serum creatine \>1.3) and cannot follow the weight-based dosing protocol for Gadavist.\*\*\*

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT05386043) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Glioma Treatment Options in Indianapolis, IN

If you're searching for glioma treatment options in Indianapolis, IN, this clinical trial (NCT05386043) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all glioma clinical trials near you to find additional studies recruiting in your area.

More Brain Cancer Trials in Indianapolis, IN

See all brain cancer clinical trials recruiting in Indianapolis — not just this study.

Browse Brain Cancer Trials in Indianapolis →

Browse More Trials by Condition

Brain Cancer TrialsAll Conditions →

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN